期刊文献+

心房颤动患者循环中凝血标志物浓度变化 被引量:1

Change of Concentration of Blood Coagulation Markers in Patients with Atrial Fibrillation
下载PDF
导出
摘要 目的研究阵发性、持续性及永久性房颤患者循环中凝血标志物的浓度变化及意义。方法阵发性房颤30例,持续性房颤22例,永久性房颤30例及正常对照组30例,分别测定循环中血浆纤维蛋白原、D-二聚体、血小板膜糖蛋白Ⅱb/Ⅲa浓度并进行比较。结果持续性及永久性房颤患者各项指标均高于阵发性房颤组,差别有显著性,阵发性房颤组与正常对照组间差别无显著性,持续性房颤与永久性房颤组间差别无显著性。结论阵发性房颤患者血中凝血指标无明显增加,而持续性与永久性房颤患者血中凝血指标增加,处于血栓前状态,应给予积极抗凝治疗。 Objective To investigate the different consentrations of blood coagulation markers in patients with atrial fibrillation(AF). Methods 82 patients with atrial fibrillation were divided into 3 groups : paroxysmal AF 30, persistent AF 22, permanent AF 30 ;30 people were selected as normal controls. The consentrations of plasma fibrinogen, D - Dimer and GP Ⅱb/Ⅲa were measured and compared in four groups. Results These markers were no significant differences between paroxysmal AF group and normal controls, but these markers in persistent AF group and permanent AF group were significant higher than those in paroxysmal AF group, there was no significant difference on the concentrations of markers between persistent AF group and permanent AF group. Conclusion The mark- ers of blood coagulation were no increasement in paroxysmal AF patients, but increasement in the persistent and permanent AF patients. There were prothrombotic state in patients with persistent AF or permanent AF, so these patients should receive treatment of anticoagulation.
机构地区 河南省人民医院
出处 《医药论坛杂志》 2006年第8期31-32,共2页 Journal of Medical Forum
关键词 心房颤动 纤维蛋白原 D-二聚体 血小板膜糖蛋白Ⅱb/Ⅲa Atrial fibrillation Fibrinogen D-Dimer GPⅡb/Ⅲa
  • 相关文献

参考文献4

  • 1金鹏,沈玉祥.血小板膜糖蛋白Ⅱb/Ⅲa评估房颤并发血栓栓塞的临床价值[J].国外医学(心血管疾病分册),2004,31(6):344-346. 被引量:5
  • 2Li-Saw-Hee FL,Blann AD,Lip GY.A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.J Am Coll Cardiol,2000,35(7):1926-1931
  • 3Li-Saw-Hee FL,Blann AD,Gurney D,et al.Plasma yon willebrand factor,fibrinogen and soluble P-selectin levels in paroxysmal,persistent and permanent atrial fibrillation:effects of cardioversion and return of left atrial function.Eur Heart J,2001,22(18):1741-1747
  • 4Giansante G,Fiotti N,Miccio M,et al.Coagulation indicators in patients with paroxysmal atrial fibrillation:effects of electric and pharmacologic cardioversion.Am Heart J,2000,140(3):423-429

二级参考文献14

  • 1孙燕淑,祁芸芸,袁家颖.房颤患者血小板膜糖蛋白Ⅱ_b/Ⅲ_a受体的变化及意义[J].中国临床医学,2001,8(1):60-61. 被引量:7
  • 2Nurden P. Transfus Clin Biol,2001 ;8(2):114-122
  • 3Abusaada K, Sharma SB,Jaladi R, et al. Am J Manag Care,2004; 10(3 Suppl) : S50-S57
  • 4Viniguerra C,Bordet JC,Beaune G,et al. Platelets,2001;12(8):486-495
  • 5Mehta YS,Ghosh K,Badakers, et al. J Lab Clin Med,2003;142(2) : 113- 120
  • 6Sorel N, Brabant S, Christiaens L, et al. Br J Haematol,2004; 124(2) :221 -223
  • 7McKenzie ME,Malinin AI, Bell CR, et al. Blood Coagul Fibrinolysis, 2003;14 (3): 249 - 253
  • 8Bornstein N, Corea F, Galllaiv, et al. Clin Exp Hypertens,2002 ; 24 (7-8) : 493 - 499
  • 9Li Saw, Hee FL, Blann AD, Lip GY. J Am Coll Cardiol,2000;35(7) : 1926-1931
  • 10Kamath S, Blann AD, Chin BS, et al. Eur Heart J, 2002;23(22) : 1788-1795

共引文献4

同被引文献7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部